Philips debuts Gyroscan CV
Philips Medical Systems has formally rolled out Gyroscan CV, the vendor’s cardiovascular MRI system. Initially highlighted at the 1998 RSNA meeting (SCAN Special Report 1/99), Gyroscan CV employs a 1.5-tesla open magnet design and features
Philips Medical Systems has formally rolled out Gyroscan CV, the vendors cardiovascular MRI system. Initially highlighted at the 1998 RSNA meeting (SCAN Special Report 1/99), Gyroscan CV employs a 1.5-tesla open magnet design and features optimized cardiovascular software, a five-element cardiac coil, and the firms EasyVision diagnostic workstation.
Gyroscan CV can provide information about cardiac anatomy and pathology; ventricular function; valvular function; wall motion, wall thickness, and thickening; myocardial perfusion; and coronary angiography, according to Philips of Best, The Netherlands. Philips believes that by using Gyroscan CV, healthcare institutions can reduce the need for x-ray and nuclear medicine scans, as well as contrast media.
One of the available options on Gyroscan CV is MobiTrak, an automated peripheral vascular angiography tool. MobiTrak, first shown at the 1996 RSNA meeting, combines contrast-enhanced 3-D MR angiography (MRA) with rapid, automatic table movement between successive coronal acquisitions. The result is high quality images from the abdominal aorta to the feet with a scan time of three to four minutes, according to Philips.
Another MRA technique, BolusTrak, provides real-time display and visual detection for contrast-enhanced procedures. With BolusTrak, the angiography acquisition can be precisely synchronized to the arrival of the bolus, according to Philips.
What a New PSMA PET/CT Study Reveals About Local PCa Treatment and High-Risk Recurrence
May 16th 2025For patients at high-risk for biochemical recurrence of prostate cancer, PSMA PET/CT findings revealed that 77 percent had one or more prostate lesions after undergoing local radiation therapy or radical prostatectomy, according to a recent study.
Can Emerging AI Software Offer Detection of CAD on CCTA on Par with Radiologists?
May 14th 2025In a study involving over 1,000 patients who had coronary computed tomography angiography (CCTA) exams, AI software demonstrated a 90 percent AUC for assessments of cases > CAD-RADS 3 and 4A and had a 98 percent NPV for obstructive coronary artery disease.
